Document is current
Any future updates will be listed below
-
Authors
Amiguet, Martina
Palau, Patricia
Domínguez, Eloy
Seller, Julia
Pinilla, Jose Manuel Garcia
de la Espriella, Rafael
Miñana, Gema
Valle, Alfonso
Sanchis, Juan
Górriz, Jose Luis
Bayés-Genís, Antoni
,
Domíngueza, Eloy
Sastre, Clara
Miñana, Gema
Santas, Enrique
Mollar, Anna
Civera, Jose
Conesa, Adriana
Zakarne, Rim
Larumbe, Ainoha
Pinilla, Jose Manuel Garcia
Doblas, Juan Jose Gómez
Mezcua, Ainhoa Robles
Miñana, Gema
Bodí, Vicent
Pascual-Figal, Domingo
Rubio, Clara Jiménez
Cabeza, Alejandro I. Pérez
Expósito, Arancha Díaz
Carmona, José David Martínez
Morales, Manuel Luna
Sánchez, Francisco J. Zafra
Trujillo, Ángel Montiel
Climent, Herminio Morillas
Núñez, Julio
-
Funding
Funding for this research was provided by:
Clinical Research Network (PT17/0017/0003)
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 22 June 2023
First Online: 30 June 2023
Competing interests
: J.S. reports speaker fees from Astra Zeneca and Boehringer Ingelheim. JMGP reports personal fees from Astra Zeneca and Esteve. JMGP reports personal fees from Astra Zeneca and Esteve. AV reports speaker fees from Astra Zeneca. R.E. reports personal fees from Astra Zeneca, Novartis, Boehringer-Ingelheim, and NovoNordisk. AV reports speaker fees from Astra Zeneca. JS has received speaker fees from Abbott Vascular and Prosmédica. JLG has received fees for participating in advisory boards and educational activities from Astra Zeneca, Boehringer-Ingelheim, NovoNordisk, Bayer, and Novartis. A.B.-G. has lectured and/or participated in advisory boards for Abbott, Astra Zeneca, Boehringer-Ingelheim, Novartis, Roche Diagnostics, and Vifor. J.N. reports personal fees from Astra Zeneca, Novartis, Boehringer-Ingelheim, Eli Lilly, Rovi, NovoNordisk, and Vifor Pharma. Other authors do not have competing interest.
